#AskDrDurie

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

Feb
14
Is the combination of Velcade, Revlimid, and dexamethasone (VRd) helpful for myeloma patients over the age of 65?
In this week’s video, Dr. Brian G.M. Durie discusses various trials that were presented at ASH and the triple therapy options that are available for myeloma patients of all ages.
Feb
06
What is a BiTE and how likely is it to help me to achieve a response and remission for my myeloma?
In this week’s video, Dr. Brian G.M. Durie discusses what BiTEs are and how they may help achieve a response in patients with myeloma. BOTTOM LINE: ​ BiTEs are new monoclonal antibody forms of(...)
Jan
31
How do you tell if you’re in remission?
In this week’s video, Dr. Brian G.M. Durie explains what remission is and how to tell whether or not you are in remission as a myeloma patient
Jan
24
Why do some doctors decide to add new treatment when myeloma protein levels increase, whereas other doctors decide to watch and wait?
In this week’s video, Dr. Brian G.M. Durie discusses whether it is best to watch and wait or to shift treatment when myeloma protein levels increase. BOTTOM LINE: ​ Early treatment or “watching and(...)
Jan
17
When discussing improvements in the available treatments for multiple myeloma, do small steps really equal progress?
In this week’s video, Dr. Brian G.M. Durie discusses whether or not small steps in the available treatments for multiple myeloma can be considered progress.
Jan
10
What is the difference between genetic testing, such as FISH testing, and DNA testing?
In this week’s video, Dr. Brian Durie identifies key takeaways for myeloma patients from the ASH 2016 abstracts.